250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 5 Life Science Angel Investors in Belgium in November 2024

A list of 5 angel investors that invest in Life science startups based in Belgium. We rank investors based on the number of investments they made in Life science companies from Belgium. We update this investor list every month.

Top 5 Life Science Angel Investors in Belgium in November 2024

Investor Life Science Belgium investments
Luc Vauterin 2
Annie Vereecken 2
Pierre Drion 2
Kenneth Buckfire 1
Evren Ucok 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Luc Vauterin Angel
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
  • Life Science, Data Integration, Data Visualization
  • Seed, Series A
  • Belgium
Portfolio highlights
  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Annie Vereecken Angel
Annie Vereecken
Show more
Investment focus
  • Biotechnology, Medical, Hospital
  • Seed, Series A, Funding Round
  • Belgium
Portfolio highlights
  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Drion Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Pierre Drion - CEO @ Petercam
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Series B, Funding Round
  • Belgium
Portfolio highlights
  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Kenneth Buckfire Angel · New York, New York, United States
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Series A
  • Belgium
Portfolio highlights
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Evren Ucok Angel · Istanbul, Istanbul, Turkey
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Series A
  • Turkey, Belgium
Portfolio highlights
  • idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Investors by country
Angel Investors in Belgium by industry